Identifying biomarkers for the transition from acute to chronic pain
Clinical Coordinating Center for the Acute to Chronic Pain Signatures Program
This study is looking at how specific biological signs can help us understand who might develop chronic pain after having acute pain, so we can create better, personalized treatment plans that help manage pain without relying on opioids.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-10441496 on NIH RePORTER |
What this research studies
This research investigates how certain biological markers can predict whether individuals will develop chronic pain after experiencing acute pain. By analyzing data from a large group of participants, the study aims to create personalized treatment strategies that reduce the need for opioids and improve pain management. The research involves collaboration among pain scientists and data management experts to ensure rigorous analysis and effective outcomes. Patients may be monitored for their pain responses and biological indicators to better understand their pain profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have recently experienced acute pain and are at risk of developing chronic pain.
Not a fit: Patients who do not have acute pain or those with pre-existing chronic pain conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective pain management strategies and reduce the reliance on opioid medications for patients.
How similar studies have performed: Previous research has shown promise in identifying biomarkers for pain management, suggesting that this approach could lead to significant advancements in the field.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Sluka, Kathleen a — University of Iowa
- Study coordinator: Sluka, Kathleen a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.